NCT01444729 2017-10-26
Post Approval Commitment Study
Endo Pharmaceuticals
Completed
Clinical Trials
3 trialsNCT00704808 2015-09-09
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Merck Sharp & Dohme LLC
Completed
NCT00316134 2011-11-08
Multiple Biomarkers in Undiagnosed Pleural Effusion
Fujirebio Diagnostics, Inc.
Terminated